Innocan Pharma Explains Liposome Technology

(1:26)

Innocan Pharma Launches its E-commerce platform!

(45)

Dr Joseph Geldwert, DPM: Innocan Pharma provides significant relief for pain

(46)

Innocan Pharma launches Derma CBD line in Europe

(3:37)

Innocan Pharma Reports a Successful Experiment With An Amputee Female Donkey

(43)

Innocan Pharma Explains Liposome Technology DE

(1:44)

Professor Chezy Barenholz about Innocan Pharma and bringing its drugs to the market

(10:30)

Iris Bincovich, CEO of Innocan Pharma

(3:5)

Nitrosamines Issue - A Regulatory Overview Scientific Webinar 2024

(50:2)

Symposium 2024 Opening Plenary — Introducing Canada's Drug Agency

(1:23:35)

Oryzon Genomics – executive interview (10 December 2024)

(22:14)

Targeted Polyclonal Antibodies | Immuron Ltd (NASDAQ: IMRN) | GCFF Virtual 2024 Bio Investing

(20:42)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

Clinical and Commercial Manufacturing of mRNA Therapeutics: Opportunities and Challenges

(58:58)

Annexin Pharmaceuticals | BioStock Life Science Summit 2024

(15:12)

Prof Daniel Offen

(10:56)

Inmed Pharma; Diving into Rare Canabinoid Manufacturing

(12:21)

Open-source Biopharmaceutical Manufacturing Ontology Webinar (March 20, 2024)

(59:10)

Innocan Provides Corporate Update - 12.2.2024

(18:38)

Innocan Pharma Reports Success in a Pre-Clinical Trial on a Paralyzed Goat

(1:18)

InnoCan Pharma $INNO Announces an Injectable CBD Milestone

(2:14)

Innocan Pharma Canine Experiment June 2022

(1:30)

Market Open: InnoCan Pharma Corporation

(1:21)

Innocan Pharma's solution moves to advanced trials

(1:26)

InnoCan Pharma - Scientific Article regarding CBD

(1:22)

InnoCan Pharma - Interview mit Iris Bincovich, CEO || Part 1

(4:38)

Another milestone achieved: LPT mass-manufacturing announced by Innocan Pharma CSE: INNO | FSE: IP4

(40)

Innocan Pharma hits major milestone in company development of CLX platform

(5:24)